For use with nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/aspirate or nasal wash. A single patient specimen can be tested for SARS-CoV-2 as well as other common respiratory viruses with symptoms that overlap with COVID-19 boosting efficiency and increasing clinical insight.

  • Run more efficiently with full automation from sample-to-result. 
  • Receive easy to interpret results. 
  • Run multiple assays from a single specimen.

The Aptima® SARS-CoV-2 Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the Aptima® SARS-CoV-2 Assay for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Aptima® SARS-CoV-2 Assay for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Aptima® SARS-CoV-2 Assay or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top